About Us

Zhuhai Midtek Biopharmaceutical Co., Ltd.

Zhuhai Midtek Biopharmaceutical Co., Ltd.

Zhuhai miditec biopharmaceutical Co., Ltd. (hereinafter referred to as miditec) is a key investment attraction project of Zhuhai City. The company is located in Sanzao jingjiawan biopharmaceutical Park, Jinwan District, covering an area of 50 mu, with a construction area of 13000 square meters (extraction workshop of 3287 square meters; solid preparation workshop of 5664 square meters), with an investment of 130 million yuan.

Zhuhai Midtek Biopharmaceutical Co., Ltd.

The company focuses on the development and production of anti-tumor drugs and their supporting large health products.

Has a number of independent research and development of national invention patents, the existing 15 national drug approval. Anti-tumor series of traditional Chinese medicines include Sanjie tablets, a new drug for the treatment of liver cancer; Baishan tablets for the treatment of lung cancer, nasopharyngeal cancer, and laryngeal cancer; Xiaojie Ling for the treatment of gastric cancer, colorectal cancer, and pancreatic cancer; Rukangning for the treatment of breast cancer and cervical cancer, etc. All have independently developed invention patents. Other products include supporting nutrition, prognosis and rehabilitation of large health products.

It is our vision to develop the national traditional Chinese medicine industry in combination with the concept of great health, carry forward the anti-tumor essence of traditional Chinese medicine, lead the trend of traditional Chinese medicine in treating modern malignant diseases, open up the modern emerging market of traditional Chinese medicine, and build the largest anti-tumor base of traditional Chinese medicine in China.